Skip to main content

The AI tools that genuinely help psychiatrists handle paperwork, not diagnosis: drafting notes, summarizing records, preparing prior authorizations and letters, and organizing symptom scores. Randomized evidence on ambient scribes shows modest time savings and less burnout. Psychiatry adds special privacy duties, so consent and note content need more care than elsewhere.

Ask psychiatrists what they want from AI and very few say “a second opinion on the diagnosis”. They say: give me back the evening I spend finishing notes. Help me with the prior authorization for the medication that works. Pull together the 300 pages of outside records before a new patient walks in.

That instinct is correct, and it is the thesis of this piece. The highest-value AI in psychiatry right now is administrative. It works on the paper around the patient, not on the judgment about the patient. Tools that stay on that side of the line are already useful. Tools that drift across it, suggesting diagnoses from a transcript or scoring a patient’s risk from their tone, bring risks psychiatry is especially poorly placed to absorb.

If you are a patient in crisis or thinking about harming yourself, please contact your local emergency services or a crisis line now. In the US, call or text 988.

What AI tools are psychiatrists actually using?

The most widely adopted category is the ambient AI scribe: software that listens to a visit, with consent, and drafts a note for the clinician to review and sign. Other common uses include generating drafts of letters, such as disability forms, school accommodations and prior authorization requests; summarizing lengthy records from previous hospitals; drafting replies to patient portal messages; and organizing symptom scale results into trends.

The American Psychiatric Association’s March 2024 position statement on augmented intelligence recognized opportunities in clinical documentation, billing and prior authorization, while urging caution about using AI for clinical decisions and about feeding patient data into AI systems. That split, enthusiasm for administration and caution for judgment, maps onto where the evidence currently sits.

Do AI scribes actually save psychiatrists time?

The best evidence is from a randomized trial across specialties rather than psychiatry alone. Published in NEJM AI in November 2025 by a UCLA team led by Lukac and Mafi, it randomized 238 outpatient physicians in 14 specialties to one of two ambient scribes, Microsoft’s DAX Copilot or Nabla, or to usual care for two months.

The results were real but modest. Physicians using Nabla reduced their time writing notes by roughly 10%, about 41 seconds per note, compared with controls. The reduction for DAX was small and not statistically significant. Both scribe groups reported improvements in burnout and cognitive load measures. Uptake was partial: the scribes were used in roughly 30% to 34% of visits in their groups.

This matches the pattern we described in Ambient AI Scribes Will Reduce Burnout Only If Nobody Spends the Time They Save. The minutes saved are small. The cognitive relief of not typing while a patient talks may matter more, and it evaporates if the organization simply adds more visits.

For psychiatry, that relief may be larger than average. A psychiatric interview depends on sustained attention to what a person says and how they say it. Looking at a keyboard instead of the patient costs more in a psychiatric evaluation than in a medication refill visit.

Why is AI documentation riskier in psychiatry?

Psychiatric records are among the most sensitive in medicine, and several features raise the stakes.

First, what goes in the note matters more. A general scribe tuned for primary care may faithfully record everything a patient says, including details about trauma, relationships, sexuality or illegal drug use that a psychiatrist would ordinarily summarize with discretion. Notes are increasingly visible to patients and may be shared with other clinicians, insurers or courts. A verbatim-style AI note can expose far more than the clinician intended.

Second, US law already treats some psychiatric information specially. HIPAA gives psychotherapy notes, a clinician’s separate process notes about therapy sessions, extra protection, generally requiring specific patient authorization for most disclosures. Records from many substance use treatment programs are protected by federal confidentiality rules known as 42 CFR Part 2. An AI workflow that merges these into the general medical record, or sends them to a vendor without appropriate agreements, can create compliance problems.

Third, consent is more complicated. Some patients will be uncomfortable with any recording, particularly those with paranoia, trauma histories or immigration concerns. Capacity to consent can fluctuate. Psychiatrists need a clear way for patients to decline without affecting their care, and a habit of asking at every visit rather than once.

Fourth, errors carry different risks. A scribe that misattributes a statement, recording “I have thought about suicide” when the patient said a friend had, creates a record that can follow a person for years. Every AI-drafted psychiatric note needs careful review before signing.

Where should the line be drawn?

Some states have begun drawing it in law. Illinois’ Wellness and Oversight for Psychological Resources Act, signed in August 2025, bars AI from making independent therapeutic decisions or detecting emotions or mental states in therapy, while explicitly allowing licensed professionals to use AI for administrative and supplementary support such as notes, scheduling and billing, with patient consent required for recorded sessions.

A practical version of the line for any psychiatric practice looks like this. Acceptable with review: drafting notes from a consented recording, summarizing outside records, drafting letters and prior authorizations, organizing questionnaire scores, and drafting patient messages for the clinician to edit. Not acceptable: AI suggesting diagnoses from a transcript, scoring a patient’s risk from voice or language, or recommending medications, unless the tool has been validated and regulated for that purpose and the clinician treats it as one input among many.

The distinction is not that administrative AI is error-free. It is that errors there are catchable by a clinician reading a draft, whereas errors in clinical inference shape judgment in ways that are hard to notice. We explored that dynamic for patient messages in The Real Risk of AI-Drafted Patient Messages Is the Doctor Who Agrees With Them: fluent drafts invite agreement.

A worked example: one psychiatrist’s week

Take a hypothetical outpatient psychiatrist seeing about 60 patients a week, a mix of new evaluations and medication follow-ups.

Before AI, she spends her evenings finishing notes, writes three or four prior authorization appeals a week by hand, and skims outside records in the minutes before new evaluations.

After adopting a set of tools, several things change. A scribe drafts follow-up notes, which she edits for discretion, removing details that do not need to be in the permanent record. A summarization tool condenses outside records into a two-page timeline of diagnoses, medications tried and hospitalizations, which she checks against the source for any key decision. A template-based tool drafts prior authorization letters from her note and the insurer’s criteria. Symptom scale results appear as a trend at the top of the chart.

If each follow-up note takes a minute or so less, and each prior authorization letter 15 minutes less, she might recover a couple of hours a week. That is not transformational, but it is an evening back. What she does not adopt is a feature that proposes diagnoses from the transcript. Her diagnostic reasoning stays hers, and so does her accountability for it.

The strongest counterargument

Some argue that restricting AI to administration wastes its potential. Psychiatry has high diagnostic variability, and there are plausible roles for decision support: flagging drug interactions, reminding clinicians of guideline-recommended next steps after failed treatments, or noticing patterns across years of records that a busy clinician might miss. Drug interaction checking is already a form of decision support that nobody objects to.

That is fair. The line is not “no clinical AI ever”. It is that clinical AI should meet clinical standards: validation in comparable patients, regulatory oversight where it claims to diagnose or treat, and a design that supports rather than anchors judgment. Most tools currently marketed to psychiatrists do not meet that bar for clinical claims, while administrative tools can deliver value today with ordinary safeguards.

There is also a sequencing argument. Practices that first learn to govern low-risk administrative AI, with consent workflows, review habits, vendor oversight and error reporting, will be far better prepared to evaluate clinical tools when validated ones arrive. Starting with the paperwork is not timidity. It is building the muscles that safe clinical AI will require.

What this means for psychiatrists, practices and vendors

For psychiatrists, the priority list is short: get explicit consent, review every draft carefully, edit notes for appropriate discretion, keep psychotherapy notes separate, and never sign a summary you have not checked against key sources. The broader documentation burden, discussed in The EHR Is Not the Burden, will not be solved by a scribe alone, but a scribe can help.

For practices and health systems, check vendor contracts for data use, retention and model training, and confirm appropriate business associate agreements and handling of 42 CFR Part 2 records. Offer patients a simple way to opt out.

For vendors, psychiatry-specific features, such as discretion settings, separate handling of psychotherapy notes and consent tracking, are a real differentiator.

Frequently asked questions

What is the best AI tool for psychiatrists?

There is no single best tool. The most useful categories are ambient scribes, record summarization, letter and prior authorization drafting, and symptom tracking. Choose tools with strong privacy agreements, psychiatric-appropriate note settings, clear consent workflows and no use of patient data for training without permission. Test with your own notes before committing.

Are AI scribes HIPAA compliant for psychiatry?

They can be, if the vendor signs a business associate agreement and handles data appropriately. Psychiatry adds complications: psychotherapy notes have extra HIPAA protections, and many substance use treatment records fall under 42 CFR Part 2. Practices should confirm how a vendor stores, retains and uses recordings and notes before adopting it.

Can AI diagnose mental illness?

No AI tool should be used to diagnose mental illness on its own. Some tools are being researched for detecting signs of depression or other conditions, but diagnosis requires a clinician’s assessment of history, context and alternative explanations. The American Psychiatric Association has urged caution in using AI for clinical decisions.

Do patients need to consent to AI scribes in psychiatry?

Consent is essential ethically and often legally, especially where state recording laws require all parties to agree. Illinois law, for example, requires patient consent before AI is used with recorded therapy sessions. Psychiatrists should explain what the tool does, allow patients to decline without consequences, and ask again if circumstances change.

How much time do AI scribes save?

Modest amounts, on current evidence. A randomized trial of 238 physicians published in NEJM AI in 2025 found one scribe cut note-writing time by about 10%, around 41 seconds per note, while another showed no significant reduction. Both groups reported less burnout and lower cognitive load, which may matter more than minutes.

The takeaway

The best AI for psychiatrists right now is the kind patients never notice: it writes the letter, drafts the note, and finds the old discharge summary, while the psychiatrist keeps looking at the person in front of them. Save the judgment for humans, and let the machines have the paperwork.

Which administrative task would you hand to AI first in your practice, and which would you never delegate?

Abhishek Shankar

Abhishek Shankar is a three-time founder and CEO of MyBabyBridge, which uses AI and data to make IVF more accessible. He writes about the gap between what works in health pilots and what survives at scale, covering financing, workforce, digital health and equity. He writes more at abhishek-shankar.com.

Leave a Reply